Core Viewpoint - The biomedicine and health industry is a crucial part of Zhuhai's "4+3" industrial cluster, with significant attention on the development of related enterprises, particularly Guichuang Tongqiao Medical Technology Co., Ltd. [1] Company Overview - Guichuang Tongqiao is a high-tech enterprise focused on the independent research and development, achievement transformation, and industrialization of neurovascular interventional medical devices, having achieved multiple technological breakthroughs since its establishment in Zhuhai in 2016 [3] - The company was recognized as a national-level specialized and innovative "little giant" enterprise in 2023 [3] - By the end of 2025, the company's sales channels are expected to cover 83 countries and regions globally, with strategic partnerships established with over 80 overseas partners [3] Strategic Development - The chairman of Guichuang Tongqiao, Zhao Zhong, emphasized the company's commitment to clinical demand-driven, differentiated innovation, and steady product portfolio expansion as the domestic medical device industry enters a phase of high-quality development [3] - The company aims to enhance its global layout and improve international operational capabilities in research, manufacturing, and commercialization [3] Innovation and Product Development - During the investor open day, the management team detailed the focus on innovative product layout, market strategies, and globalization strategies, showcasing several domestic and overseas products [3] - The company introduced its first domestically produced fully visible distal closure mesh stent, designed for the treatment of intracranial aneurysms, which offers better visibility and safety during procedures compared to similar products on the market [7] Infrastructure and Investment - The Zhuhai Innovation Base, where the event took place, was constructed in 2022 with a total investment of 2 billion yuan, covering an area of approximately 16,000 square meters and a planned total building area of about 58,000 square meters [5] - This base is crucial for the company's R&D, certification, and large-scale production of various products, providing a solid foundation for innovation and global development [5] Future Goals - Since its listing in 2021, the company has consistently met its performance targets and aims to further expand into overseas markets, seeking exponential growth through product exports and mergers and acquisitions [8] - The company plans to enhance product quality and international competitiveness, targeting markets in Europe, South Korea, Southeast Asia, and countries along the Belt and Road Initiative [8]
产品远销83个国家和地区！珠海这家上市公司举办开放日活动